Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2021 Volume 22 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2021 Volume 22 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway

  • Authors:
    • Jin Peng
    • Xijiang Liu
    • Chengcheng Li
    • Min Gao
    • Hongyan Wang
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250001, P.R. China, Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China
    Copyright: © Peng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 1102
    |
    Published online on: August 2, 2021
       https://doi.org/10.3892/etm.2021.10535
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Although lymphatic endothelial cells (LECs) serve a positive role in tumor lymphatic metastasis, the regulation of LECs undergoing migration similar to that of tumor cells remains poorly understood. A previous study revealed that semaphorin 4C (Sema4C) could be a marker of LECs in cervical cancer. Thus, the present study aimed to understand the mechanism via which Sema4C could promote the development of tumor‑associated characteristics in LECs in cervical cancer. Primary tumor‑associated LECs (TLECs) were distinguished from cervical cancer by flow cytometry. The promigratory ability was assessed using the Transwell assay. Lentivirus infection was used to alter the expression of Sema4C in TLECs. Confocal laser scanning was used to determine the infection efficiency of lentivirus infection. Sema4C/ERK/E‑cadherin pathway was measured by reverse transcription‑quantitative PCR and western blotting. The co‑localization of Sema4C and the lymphatic marker lymphatic vessel endothelial hyaluronan receptor 1 was verified. Primary tumor‑associated LECs (TLECs) were isolated from a mouse xenograft cervical tumor model. It was revealed that overexpressing Sema4C stimulated the migratory ability of TLECs, downregulated E‑cadherin expression and stimulated ERK phosphorylation, whereas knocking down Sema4C had the opposite effects. The treatment of PD98059 (ERK inhibitor) blocked the pro‑migratory ability of TLECs, which indicated a dependence on the ERK signaling pathway. It was identified that the Sema4C/ERK/E‑cadherin pathway may be critical for the migration of TLECs, which may promote lymph node metastasis. Therefore, Sema4C could be a promising target for the treatment of cervical cancer with lymphatic metastasis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Frumovitz M: Sentinel lymph node biopsy for cervical cancer patients-what's it gonna take? Gynecol Oncol. 144:3–4. 2017.PubMed/NCBI View Article : Google Scholar

2 

Li H, Wu X and Cheng X: Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 27(e43)2016.PubMed/NCBI View Article : Google Scholar

3 

Hoshino A and Lyden D: Metastasis: Lymphatic detours for cancer. Nature. 546:609–610. 2017.PubMed/NCBI View Article : Google Scholar

4 

Lucas ED and Tamburini BAJ: Lymph node lymphatic endothelial cell expansion and contraction and the programming of the immune response. Front Immunol. 10(36)2019.PubMed/NCBI View Article : Google Scholar

5 

Saito A: EMT and EndMT: Regulated in similar ways? J Biochem. 153:493–495. 2013.PubMed/NCBI View Article : Google Scholar

6 

Kourtidis A, Lu R, Pence LJ and Anastasiadis PZ: A central role for cadherin signaling in cancer. Exp Cell Res. 358:78–85. 2017.PubMed/NCBI View Article : Google Scholar

7 

Wang SH, Chang JS, Hsiao JR, Yen YC, Jiang SS, Liu SH, Chen YL, Shen YY, Chang JY and Chen YW: Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells. Oncogene. 36:1503–1515. 2017.PubMed/NCBI View Article : Google Scholar

8 

Lee HR, Li F, Choi UY, Yu HR, Aldrovandi GM, Feng P, Gao SJ, Hong YK and Jung JU: Deregulation of HDAC5 by viral interferon regulatory factor 3 plays an essential role in Kaposi's sarcoma-associated herpesvirus-induced lymphangiogenesis. mBio. 9:e02217–17. 2018.PubMed/NCBI View Article : Google Scholar

9 

Jiang L, Hao C, Li Z, Zhang P, Wang S, Yang S, Wei F and Zhang J: miR-449a induces EndMT, promotes the development of atherosclerosis by targeting the interaction between AdipoR2 and E-cadherin in Lipid Rafts. Biomed Pharmacother. 109:2293–2304. 2019.PubMed/NCBI View Article : Google Scholar

10 

Wu H, Wang X, Liu S, Wu Y, Zhao T, Chen X, Zhu L, Wu Y, Ding X, Peng X, et al: Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway. Eur J Cell Biol. 86:331–344. 2007.PubMed/NCBI View Article : Google Scholar

11 

Elder AM, Tamburini BAJ, Crump LS, Black SA, Wessells VM, Schedin PJ, Borges VF and Lyons TR: Semaphorin 7A promotes macrophage-mediated lymphatic remodeling during postpartum mammary gland involution and in breast cancer. Cancer Res. 78:6473–6485. 2018.PubMed/NCBI View Article : Google Scholar

12 

Acker DWM, Wong I, Kang M and Paradis S: Semaphorin 4D promotes inhibitory synapse formation and suppresses seizures in vivo. Epilepsia. 59:1257–1268. 2018.PubMed/NCBI View Article : Google Scholar

13 

Sakurai A, Doci CL and Gutkind JS: Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res. 22:23–32. 2012.PubMed/NCBI View Article : Google Scholar

14 

Doçi CL, Mikelis CM, Lionakis MS, Molinolo AA and Gutkind JS: Genetic identification of SEMA3F as an antilymphangiogenic metastasis suppressor gene in head and neck squamous carcinoma. Cancer Res. 75:2937–2948. 2015.PubMed/NCBI View Article : Google Scholar

15 

Nasarre P, Gemmill RM and Drabkin HA: The emerging role of class-3 semaphorins and their neuropilin receptors in oncology. Onco Targets Ther. 7:1663–1687. 2014.PubMed/NCBI View Article : Google Scholar

16 

Wei JC, Yang J, Liu D, Wu MF, Qiao L, Wang JN, Ma QF, Zeng Z, Ye SM, Guo ES, et al: Tumor-associated lymphatic endothelial cells promote lymphatic metastasis by highly expressing and secreting SEMA4C. Clin Cancer Res. 23:214–224. 2017.PubMed/NCBI View Article : Google Scholar

17 

Albini A, Mirisola V and Pfeffer U: Metastasis signatures: Genes regulating tumor-microenvironment interactions predict metastatic behavior. Cancer Metastasis Rev. 27:75–83. 2008.PubMed/NCBI View Article : Google Scholar

18 

Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, Cifdaloz M, Catena X, Calvo TG, Cañón E, et al: Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature. 546:676–680. 2017.PubMed/NCBI View Article : Google Scholar

19 

Young YK, Bolt AM, Ahn R and Mann KK: Analyzing the tumor microenvironment by flow cytometry. Methods Mol Biol. 1458:95–110. 2016.PubMed/NCBI View Article : Google Scholar

20 

Lukacs-Kornek V: The role of lymphatic endothelial cells in liver injury and tumor development. Front Immunol. 7(548)2016.PubMed/NCBI View Article : Google Scholar

21 

Faustino-Rocha A, Oliveira PA, Pinho-Oliveira J, Teixeira-Guedes C, Soares-Maia R, da Costa RG, Colaço B, Pires MJ, Colaço J, Ferreira R and Ginja M: Estimation of rat mammary tumor volume using caliper and ultrasonography measurements. Lab Anim (NY). 42:217–224. 2013.PubMed/NCBI View Article : Google Scholar

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

23 

Humbert M, Hugues S and Dubrot J: Shaping of peripheral T cell responses by lymphatic endothelial cells. Front Immunol. 7(684)2016.PubMed/NCBI View Article : Google Scholar

24 

Ji RC: Lymph nodes and cancer metastasis: New perspectives on the role of intranodal lymphatic sinuses. Int J Mol Sci. 18(51)2016.PubMed/NCBI View Article : Google Scholar

25 

Potenta S, Zeisberg E and Kalluri R: The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer. 99:1375–1379. 2008.PubMed/NCBI View Article : Google Scholar

26 

Cho JG, Lee A, Chang W, Lee MS and Kim J: Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction. Front Immunol. 9(294)2018.PubMed/NCBI View Article : Google Scholar

27 

Harris AR, Perez MJ and Munson JM: Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. BMC Cancer. 18(718)2018.PubMed/NCBI View Article : Google Scholar

28 

Mumblat Y, Kessler O, Ilan N and Neufeld G: Full-length semaphorin-3C Is an inhibitor of tumor lymphangiogenesis and metastasis. Cancer Res. 75:2177–2186. 2015.PubMed/NCBI View Article : Google Scholar

29 

Lawson CD and Ridley AJ: Rho GTPase signaling complexes in cell migration and invasion. J Cell Biol. 217:447–457. 2018.PubMed/NCBI View Article : Google Scholar

30 

Lee G, Kim HJ and Kim HM: RhoA-JNK regulates the E-cadherin junctions of human gingival epithelial cells. J Dent Res. 95:284–291. 2016.PubMed/NCBI View Article : Google Scholar

31 

Connor AL, Kelley PM and Tempero RM: Lymphatic endothelial lineage assemblage during corneal lymphangiogenesis. Lab Invest. 96:270–282. 2016.PubMed/NCBI View Article : Google Scholar

32 

Hou WH, Liu IH, Tsai CC, Johnson FE, Huang SS and Huang JS: CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin. J Cell Sci. 124:1231–1244. 2011.PubMed/NCBI View Article : Google Scholar

33 

Zhou QD, Ning Y, Zeng R, Chen L, Kou P, Xu CO, Pei GC, Han M and Xu G: Erbin interacts with Sema4C and inhibits Sema4C-induced epithelial-mesenchymal transition in HK2 cells. J Huazhong Univ Sci Technolog Med Sci. 33:672–679. 2013.PubMed/NCBI View Article : Google Scholar

34 

Marchese V, Juarez J, Patel P and Hutter-Lobo D: Density-dependent ERK MAPK expression regulates MMP-9 and influences growth. Mol Cell Biochem. 456:115–122. 2019.PubMed/NCBI View Article : Google Scholar

35 

Tang FY, Chiang EP, Chung JG, Lee HZ and Hsu CY: S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer. J Nutr Biochem. 20:1013–1020. 2009.PubMed/NCBI View Article : Google Scholar

36 

Kawata K, Yugi K, Hatano A, Kokaji T, Tomizawa Y, Fujii M, Uda S, Kubota H, Matsumoto M, Nakayama KI and Kuroda S: Reconstruction of global regulatory network from signaling to cellular functions using phosphoproteomic data. Genes Cells. 24:82–93. 2019.PubMed/NCBI View Article : Google Scholar

37 

Wick N, Saharinen P, Saharinen J, Gurnhofer E, Steiner CW, Raab I, Stokic D, Giovanoli P, Buchsbaum S, Burchard A, et al: Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics. 28:179–192. 2007.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Peng J, Liu X, Li C, Gao M and Wang H: Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway. Exp Ther Med 22: 1102, 2021.
APA
Peng, J., Liu, X., Li, C., Gao, M., & Wang, H. (2021). Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway. Experimental and Therapeutic Medicine, 22, 1102. https://doi.org/10.3892/etm.2021.10535
MLA
Peng, J., Liu, X., Li, C., Gao, M., Wang, H."Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway". Experimental and Therapeutic Medicine 22.4 (2021): 1102.
Chicago
Peng, J., Liu, X., Li, C., Gao, M., Wang, H."Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway". Experimental and Therapeutic Medicine 22, no. 4 (2021): 1102. https://doi.org/10.3892/etm.2021.10535
Copy and paste a formatted citation
x
Spandidos Publications style
Peng J, Liu X, Li C, Gao M and Wang H: Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway. Exp Ther Med 22: 1102, 2021.
APA
Peng, J., Liu, X., Li, C., Gao, M., & Wang, H. (2021). Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway. Experimental and Therapeutic Medicine, 22, 1102. https://doi.org/10.3892/etm.2021.10535
MLA
Peng, J., Liu, X., Li, C., Gao, M., Wang, H."Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway". Experimental and Therapeutic Medicine 22.4 (2021): 1102.
Chicago
Peng, J., Liu, X., Li, C., Gao, M., Wang, H."Sema4C modulates the migration of primary tumor‑associated lymphatic endothelial cells via an ERK‑mediated pathway". Experimental and Therapeutic Medicine 22, no. 4 (2021): 1102. https://doi.org/10.3892/etm.2021.10535
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team